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We have examined the ribosomal protein kinase activities in partially purified cytoplasmic extracts from HeLa cells infected with vaccinia virus. 
We found an activity or activities, absent from mock-infected cells, that was capable of phosphorylating the proteins S2 and S13 in vitro. The 
ribosomes phosphorylated in vitro exhibited the same multiple phosphorylation of S2 found in vivo, at least 3 phosphoryl residues being seen, 
and the same mono-phosphorylation of S13. Also as in vivo, ribosomal protein S2 contained phosphothreonine as well as phosphoserine, whereas 
S13 contained only phosphoserine. This strongly suggests that these new protein kinase activities are responsible for the ribosomal protein phos- 
phorylations that occur during infection with vaccinia virus. 
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1. INTRODUCTION 
The importance of protein phosphorylation in the in- 
fectious strategy of many lytic eukaryotic viruses is now 
becoming appreciated [11. In the case of vaccinia virus, 
changes in the phosphorylation of specific 40 S 
ribosomal proteins during infection of HeLa cells were 
originally detected some years ago [2,3]. In addition to 
an increase in the phosphorylation of ribosomal protein 
S6, normally the only phosphorylated protein of the 
40 S ribosomal subunit, there was phosphorylation de 
nova of two proteins which had never been reported to 
be phosphorylated in uninfected cells. One of these was 
clearly identified as ribosomal protein S2. The other - 
initially designated as ribosomal protein S16 [3] - is, in 
fact, ribosomal protein S13, as was established using 
several systems of two-dimensional gel analysis in our 
more recent study of the phosphorylation of Ehrlich 
ascites tumour cells infected with vaccinia virus [4]. We 
found 3-4 sites of phosphorylation on ribosomal pro- 
tein S2, and confirmed the phosphorylation of one 
phosphate group per molecule of S13. With the cells 
and conditions that we used there was no increase in the 
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phosphorylation of ribosomal protein S6, suggesting 
that a protein kinase(s) distinct from a ribosomal pro- 
tein S6 kinase might be responsible for the 
phosphorylation of ribosomal proteins S2 and S13. 
The function of these new ribosomal protein 
phosphorylations is not known, but their temporal 
association with the switch to predominant ranslation 
of viral mRNA raises the possibility that they could 
have a role in modulating this switch. A prerequisite for 
studying the effects of these phosphorylations on the 
function of the ribosomes is the identification and 
purification of the protein kinase(s) that catalyzes 
them. Although a protein kinase activity has previously 
been isolated from vaccinia virus cores [5,6], it is not 
known whether it can phosphorylate ribosomes. In our 
own previous work we did observe some phosphoryla- 
tion of S2 when ribosomes were incubated with vac- 
cinia virus cores; but this was limited to a single 
phosphoryl group, and our attempts to solubilize a 
ribosomal protein kinase activity of the appropriate 
specificity from the virions were unsuccessful [4]. We 
therefore decided to focus our attention on cytoplasmic 
extracts isolated from infected cells. We report here the 
identification of a new protein kinase activity, or ac- 
tivities, capable of reproducing the phosphorylations of 
ribosomal proteins S2 and S13 that occur during infec- 
tion by vaccinia virus in vivo. 
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2. EXPERIMENTAL allows resolution f the phosphorylated forms of ribosomal proteins 
S2 and S13 [4,8,9]. 
HeLa cells were maintained in suspension culture and infected (or 
mock-infected) with vaccinia virus (WR strain) at 7 plaque-forming 
units per cell. Cells and virus were kindly provided by B. Moss. Cells 
were harvested 4 h later and ribosomes and post-ribosomal super- 
natants were isolated as previously described [7]. In brief, the cells 
were washed with phosphate-buffered saline, resuspended in 1 vol. of 
hypertonic buffer (10 mM Tris-HCl (pH 7.5), 10 mM KCl, 1.5 mM 
magnesium acetate, 1 mM EGTA and 40~g/ml phenylmethyl- 
sulphonyl fluoride), and then ruptured with a Dounce homogenizer. 
The crude extract was centrifuged for 30 min at 10000 rpm in a Sor- 
vall SS34 rotor, and the supernatant re-centrifuged for 90 min at 
50000 rpm in a Beckman Ti50 rotor. Ribosomes for analysis of en- 
dogenous protein kinase activity were resuspended at a concentration 
of 100 A260 units per ml, and those for use as substrate for exogenous 
protein kinase (in this case only those from uninfected cells) were 
washed in 1 M KCI, recentrifuged, resuspended and stored at 
-70°C. The post-ribosomal supernatant was either stored at -70°C 
or, before DEAE-cellulose chromatography (as described in the 
legend to fig.2), dialyzed overnight against 20 mM Tris-HCl (PH 
7.5), 1 mM EDTA, 1 mM EGTA, 10 mM 2-mercaptoethanol and 
40 /g/ml phenylmethylsulphonyl fluoride. 
The protein kinase assays were essentially as previously described 
[7]. The standard assay mixture contained 20 mM Tris-HCI (pH 7.5), 
50 mM KCl, 10 mM MgClz, 10 mM 2-mercaptoethanol, 50 pM ATP 
(1 pCi of [y-‘*P]ATP) and substrate and enzyme (and any variations 
from the foregoing) as indicated in the figure legends. Incubation was 
for 30 min at 30°C. 
The radioactively-labelled reaction products were analyzed either 
by one-dimensional gel electrophoresis under denaturing conditions, 
or by two-dimensional gel electrophoresis in ‘system III’, which 
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Fig. 1. Endogenous and exogenous ribosomal protein kinase activities 
induced in cells infected with vaccinia virus. Ribosomes and post- 
ribosomal supernatants were isolated from HeLa cells and assayed 
for protein kinase activity in an 80 ~1 reaction mixture as described 
in section 2, but at 110 mM KCl, and subjected to SDS gel 
electrophoresis. The figure shows a composite autoradiograph from 
mixtures containing either 4 A260 units of crude ribosomes from cells 
infected with vaccinia virus (lane 2) or mock-infected cells (lane 1); 
or mixtures containing 3.2 A260 units of salt-washed ribosomes from 
mock-infected cells (lanes 4, 6, 8 and lo), or mixtures containing no 
ribosomes (lanes 3, 5, 7 and 9) to which were added 20 pl undialyzed 
(lanes 3-6) or dialyzed (lanes 7-10) post-ribosomal supernatant from 
cells infected with vaccinia virus (lanes 3, 4, 7 and 8) or from mock- 
infected cells (lanes 5, 6, 9 and 10). 
3. RESULTS 
First we examined the endogenous ribosomal protein 
kinase activity of crude ribosomes from mock-infected 
cells and cells infected with vaccinia virus. It can be 
seen from fig. 1 (lanes 1 and 2) that there was a clear dif- 
ference between these: the ribosomes from infected 
cells had much greater endogenous protein kinase ac- 
tivity against a protein of about 34000 relative 
molecular mass. This protein kinase activity was also 
present in the post-ribosomal supernatant, as shown by 
the exogenous phosphorylation of salt-washed 
ribosomes from uninfected cells (fig. 1, lanes 3-6). The 
size of the phosphorylated protein was consistent with 
it being either or both of ribosomal proteins S2 or S6. 
However, it should be noted that after dialysis of the 
supernatants an endogenous phosphoprotein of a 
similar electrophoretic mobility became apparent 
(fig. 1, lanes 7-10). Preliminary two-dimensional gel 
electrophoresis did, in fact, demonstrate phosphoryla- 
CPM 
x10-4. 
KCI 
-.4 
2. 
I 
1’. I I I I/, 1 -0 L I , ; ,- I , 1 
10 20 30 40 50 60 70 
FRACTION NUMBER 
Fig.2. DEAE-cellulose chromatography of post-ribosomal 
supernatant from HeLa cells infected with vaccinia virus. A dialyzed 
extract from 6 x 10’ infected cells (about 30 mg protein) was applied 
to an equilibrated 2.5 x 1 .O cm DEAE-cellulose column, washed with 
25 ml of dialysis buffer, and then eluted with a 50 ml gradient of 
O-350 mM KC1 at a flow rate of 12 ml/h, corresponding to the 
fractions 26-75. Protein kinase assays were performed on 40~1 
column fractions as described in section 2 in 120 ~1 reaction mixtures 
containing 0.8 mg/ml of either protamine (P, H), mixed 
histones (H, o--o) or casein (C, a), and radioactivity 
precipitated by trichloroacetic acid was measured. An identical 
chromatographic separation of an extract of mock-infected cells (not 
illustrated) showed a similar pattern for these substrates. The 
horizontal bars indicate the position of ribosomal protein S2 and S13 
kinase activity, assayed as described in the legend to fig.3. The 
protein kinase not bound to the column probably results from 
overloading in order to maintain a high concentration of protein. 
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Fig.3. Polyacrylamide gel electrophoresis of ribosomal proteins 
phosphorylated in vitro by protein kinase activity partially purified 
by DEAF-cellulose chromatography. Assays were performed in 25 ~1 
reaction mixtures as described in section 2, but at 36 mM Tris-HCl 
(pH 7.5) and 100 mM KCI, and polyacrylamide gel electrophoresis 
performed in the presence of SDS. The lanes 2 and 3 of the resulting 
autoradiograph correspond to reaction mixtures containing 0.3 A260 
units of salt-washed ribosomes as substrate (lanes 1 and 4 were from 
reactions with no exogenous ubstrate); lanes 1 and 2 correspond to 
reactions containing 10 ~1 of DEAE-cellulose fraction 38 from cells 
infected with vaccinia virus (fig.2), and lanes 3 and 4 to reactions 
containing lop1 of the corresponding fraction from an identical 
chromatographic separation of an extract of mock-infected cells. The 
relative molecular masses of protein standards are indicated, and 
arrowheads in lane 2 point to the 48 kDa and 17 kDa proteins 
mentioned in the text. 
tion of protein S2 (and S13) when ribosomes were in- 
cubated with dialyzed post-ribosomal supernatant from 
infected cells (not shown, but cf. fig.4). However it was 
clearly desirable to obtain a more purified preparation 
of the activities in the post-ribosomal supernatant. 
To this end we subjected the post-ribosomal superna- 
tant to DEAE-cellulose chromatography, using the 
same KC1 gradient that we had previously employed to 
determine the positions of migration of some of the 
cellular protein kinases (fig.2). In doing this we en- 
countered a technical problem in assaying the S2 kinase 
by one-dimensional gel electrophoresis. This was 
because the extract of infected cells contained a similar- 
ly sized 34 kDa phosphoprotein substrate which 
became apparent during the purification (fig.3, lane 1). 
Nevertheless it was possible to judge that the S2 kinase 
was present in fractions 39-60 (ca. 0.08-0.25 M KC1 - 
see fig.2), starting to elute just after the main peak of 
protamine kinase activity, which corresponds to pro- 
tein kinase C [7]. Also apparent to a greater extent in 
DEAE-cellulose fractions from infected than 
uninfected cells was a phosphorylated protein of 
17 kDa, the size of ribosomal protein S13 (fig.3, lane 
2). This assignation, and that of S2, were confirmed by 
two-dimensional gel electrophoresis - see below. In 
contrast to the S2 kinase activity, the S13 kinase activi- 
ty eluted as a single peak at about 0.08 M KC1 (frac- 
tions 34-44 - see fig.2). We were aided in locating the 
S13 kinase by another substrate on the salt-washed 
ribosomes: a protein of 48 kDa (fig.3, lane 2), that was 
not detected in the two-dimensional separation of basic 
proteins in fig.4, presumably because it has an isoelec- 
tric point of less than 8.6. 
For unequivocal identification of the ribosomal pro- 
teins phosphorylated, and to determine the number of 
phosphorylated forms, two-dimension gel elec- 
trophoresis was performed (fig.4). It can be seen 
(frames A and C) that the ribosomal proteins 
phosphorylated by column fraction 39 from fig.2 were 
S2 and S13, whereas the corresponding fraction from 
an experiment with mock-infected cells showed no 
kinase activity against these proteins. The 
phosphorylated forms of S2 and S13 could also be seen 
on inspection of gels after staining with Coomassie blue 
(results not shown). In all cases there was minor 
phosphorylation of ribosomal protein S6, but this was 
no greater in the fraction from infected cells than in 
that from the mock-infected cells. (It should be men- 
tioned that &glycerol phosphate was not included dur- 
ing extraction, so that any pre-existing or induced 
cellular S6 kinase would be expected to have been inac- 
tivated [lo].) Another important feature of the two- 
dimensional gel analysis in fig.4 is that it reveals the 
presence of at least 3 phosphorylated forms of 
ribosomal protein S2, as are found during infection in 
vivo [3,4]. Although there was insufficient radioactivity 
incorporated to analyze each species separately, both 
phosphothreonine and phosphoserine were found in S2 
eluted from the two-dimensional gel (results not 
shown), also consistent with the characteristics of the 
phosphorylation in vivo. Similarly only one phosphate 
group was added to protein S13 during phosphoryla- 
tion in vitro (fig.4), and was present on seryl residues, 
as previously found in vivo [4]. 
The clearest evidence that different protein kinases 
might be responsible for phosphorylating ribosomal 
proteins S2 and S13, as mentioned above, is also pro- 
vided by fig.4. Thus, S2 kinase activity, but almost no 
S13 kinase activity, was present in column fractions 46 
(fig.4, frame D), 53 and 60 (results not shown). The 
observation that the S2 kinase activity did not elute as 
a single discrete peak indicates the presence of multiple 
forms on the column, although we do not suggest hat 
these necessarily exist in the infected cell. 
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Fig.4. Two-dimensional gel electrophoresis of ribosomal proteins phosphorylated in vitro by protein kinase activity partially purified by DEAE- 
cellulose chromatography. The protein kinase assay was similar to that described in the legend to fig.3, but contained 7.5 4260 units of ribosomes. 
The ribosomes phosphorylated in vitro were sedimented through a cushion containing 1 M KCl, and the proteins analyzed by two-dimensional 
gel electrophoresis using ‘system III’ [4,8,9]. The figure shows autoradiographs from reactions with different enzyme fractions (10 ~1): (A) DEAE- 
cellulose fraction 39 from mock-infected cells; (B, C and D) DEAE-cellulose fractions 32, 39 and 46, respectively, from cells infected with vaccinia 
virus. The position of the unphosphorylated forms of ribosomal proteins S2, S6 and S13 are indicated by circles, and the different phosphorylated 
forms of S2 and S6 are designated a, b, c and d, each corresponding to the addition of a single phosphoryl residue, as the pH in the first dimension 
(pH 8.6) is close to the pl of the basic ribosomal proteins. Autoradiographs corresponding to fractions 32 and 46 from mock-infected cells are 
not illustrated as these were similar to that shown in frame A. 
4. DISCUSSION 
This work demonstrates that the soluble fraction of 
cells infected with vaccinia virus contains a protein 
kinase or kinases, absent from uninfected cells, that 
can reproduce in vitro the phosphorylations of 
ribosomal proteins S2 and S13 occurring during infec- 
tion in vivo. It is therefore most likely that we have 
identified the kinase(s) responsible for catalyzing these 
phosphorylations during infection. It should be stress- 
ed that no known cellular protein kinase has specificity 
for either or both of these ribosomal proteins in vitro 
(see e.g. [ll-141). 
The results presented here also raise some other in- 
teresting questions about the protein kinase activity. 
One is the indication, aheady discussed, that there is 
more than one kinase activity induced; the other is that 
the kinase activity or activities also have other 
physiological substrates, such as the 34 kDa 
phosphoprotein (presumed to be viral) detected in 
fig.3. These questions can only be answered through 
further purification, as can that of the genetic origin of 
the kinase(s) - virus or host. Until recently protein 
kinases were not known to be part of the stable genetic 
repertoire of eukaryotic viruses 111, but it is now clear 
that members of another family of large DNA viruses, 
the a-herpes viruses, encode at least one [ 151, if not two 
[16], such enzymes. It is therefore possible that the 
ribosomal protein kinase activities induced during in- 
fection by vaccinia virus are encoded by the viral 
genome. If this proves to be the case, the combination 
of viral genetics with enzyme purification will be 
powerful tools in elucidating the function of the 
phosphorylation of these ribosomal proteins. 
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